Similar articles

• Effects of mazindol in two patients with Prader-Willi syndrome.

  Itoh M, Koeda T, Ohno K, Takeshita K. Itoh M, et al. Pediatr Neurol. 1995 Nov;13(4):349-51. doi: 10.1016/0887-8994(95)00216-2. Pediatr Neurol. 1995. PMID: 8771175
• [Long-term treatment of patients with obesity using mazindol and a reducing diet].

  van Seters AP, Bouwhuis-Hoogerwerf ML, Goslings BM, van Nieuwkoop L, van Slooten H, Struijk-Wielinga T. van Seters AP, et al. Ned Tijdschr Geneeskd. 1982 May 29;126(22):990-4. Ned Tijdschr Geneeskd. 1982. PMID: 7110390 Clinical Trial. Dutch. No abstract available.
• Clinical studies with mazindol.

  Inoue S. Inoue S. Obes Res. 1995 Nov;3 Suppl 4:549S-552S. doi: 10.1002/j.1550-8528.1995.tb00226.x. Obes Res. 1995. PMID: 8697057 Review.
• Treating diabetes mellitus in Prader-Willi syndrome with Exenatide.

  Seetho IW, Jones G, Thomson GA, Fernando DJ. Seetho IW, et al. Diabetes Res Clin Pract. 2011 Apr;92(1):e1-2. doi: 10.1016/j.diabres.2010.12.009. Epub 2011 Jan 11. Diabetes Res Clin Pract. 2011. PMID: 21227526
• [Mazindol].

  Mori Y. Mori Y. Nihon Rinsho. 2011 Jan;69 Suppl 1:683-6. Nihon Rinsho. 2011. PMID: 21766681 Review. Japanese. No abstract available.